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ABSTRACT
Objective: The growing concern over the burden of psychiatric illnesses in health statistics elicit the importance of rational prescribing of psychotropic 
drugs. Due to the minimal number of studies conducted in this area, the present study was carried out to assess the morbidity pattern and prescribing 
trend of drugs used in psychiatric outpatients.
Methods: This prospective observational study was conducted for a period of 6-month in a psychiatric outpatient department. The medical records 
of 202 patients were reviewed for analyzing the prescription pattern using the World Health Organization drug indicators, wherein patients were 
categorized according to the International Classification of Diseases-10 criteria.
Results: In the present study, 129 (63.9%) of the 202 patients were males. The majority of the patients (36.63%) were in the age group of 25-35 years. 
Substance-related disorders (28.71%) were the most common psychiatric disorders followed by schizophrenia and other psychotic disorders 
(22.77%). Anxiolytics and hypnotics (31.99%) were the most commonly prescribed psychotropic drug class followed by antipsychotics (20.2%) and 
antidepressants (18.18%) with clonazepam (47.89%), risperidone (42.5%), and escitalopram (57.4%) being the most common drugs, respectively. 
Polypharmacy was found in 93.56% of the prescriptions with an average of 3.396 drugs/prescription. Generic drug usage (39.94%) was found to be 
low when compared to the brand drug usage (60.05%).
Conclusion: Benzodiazepines were the most commonly used psychotropic drugs. Polypharmacy, although practiced as a treatment strategy to 
manage psychiatric illnesses, predisposes patients to adverse events and adherence issues.
Keywords: Drug utilization pattern, Psychotropic drugs, Polypharmacy, Psychiatric outpatients.
INTRODUCTION
Psychiatric disorders are gaining importance in today’s world 
which is governed by globalization and competition. The National 
Institute of Family Welfare in India states that 2-3% of the 
population is suffering from serious debilitating mental disorders 
or epilepsy and about 10.4-53% visit general medicine outpatient 
department (OPD) with mental conditions. The majority of the 
psychiatric population needs long-term or even life-long therapy 
with psychotropics. However, these drugs often affect emotion and 
cognition wherein significant clinical, legal, and psychological issues 
are being observed [1,2].
In a developing country like India, where almost all psychotropic 
medications are available, very few studies have been conducted to 
evaluate the psychotropic drug utilization pattern [3]. The World Health 
Organization (WHO) has defined drug utilization study as a study 
of marketing, distribution, prescription, and use of drugs in society, 
with special emphasis on the resulting medical, social, and economic 
implications [4]. Drug utilization studies provide insight into the 
efficacy of drugs and show variations in prescribing trends and pattern 
of polypharmacy [5,6]. The most common reasons behind multiple 
drug use or polypharmacy are to treat two pathophysiologically yet 
distinct but comorbid illness, augmentation of the efficacy of primary 
treatment, reduction or management of adverse effects of primary 
treatment [6]. However, with increased treatment regimen complexity, 
concerns regarding possibility of cumulative toxicity, undesirable side 
effects as well as adherence issues emerge with polypharmacy [7]. 
Medication nonadherence, in turn, may increase the risk of relapse and 
rehospitalization which can have a major impact on the course of illness 
and treatment outcomes [8].
Even though the incidence of polypharmacy and adverse drug reactions 
have been substantially reduced with the usage of the newer generation 
of psychotropics, extensive studies on their prescribing and usage need 
to be carried out [9,10]. Hence, the present study was conducted to 
analyze the drug utilization pattern of psychotropics in the psychiatric 
OPD at a tertiary care teaching hospital.
METHODS
This hospital-based prospective observational study was carried out 
in outpatients of the Psychiatry Department of M. S. Ramaiah Medical 
Teaching Hospital (MSRMTH), Bengaluru, Karnataka, for a period of 
6-month from January 2015 to June 2015. The complete project was 
done in accordance with the permission granted by MSRMTHs Ethics 
Committee. Patients diagnosed with a psychiatric disorder, regardless 
of sex, and comorbidities were enrolled as per inclusion and exclusion 
criteria. Patient’s case notes, medication charts, lab reports, previous 
outpatient and inpatient records, and other relevant documents were 
reviewed, and details were recorded in a predesigned structured pro 
forma to analyze the drug utilization pattern. The Statistical Package 
for the Social Science (SPSS) Version 20.0 was used to analyze data. The 
WHO drug use indicators were used for analyzing the prescriptions.
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Inclusion criteria
Patients of either gender attending the OPD of psychiatric setting and 
patients treated with one or more psychopharmacological agents in 
psychiatric OPD were selected.
Exclusion criteria
Patients treated on an inpatient basis; patients treated with 
nonpsychopharmacological therapy, patients who were agitated and 
uncooperative were excluded from the study.
RESULTS
A total of 202 patients satisfied inclusion criteria and a male preponderance 
(63.86%) was observed in the study population. The majority of patients 
belonged to the age group of 25-35 years (36.63%). Morbidity pattern 
showed increased frequency with substance-related disorders (28.71%) 
followed by schizophrenia and other psychotic disorders (22.77%) and 
anxiety disorders (18.81%) (Fig. 1). Benzodiazepines (BZDs) (28.96%), 
antidepressants (18.18%), and atypical antipsychotics (18.18%) were 
the most common categories of drugs prescribed.
The most frequently prescribed BZDs have been clonazepam 
(47.89%), diazepam (21.05%), and lorazepam (18.95%). Among the 
antidepressants, escitalopram (57.4%) and sertraline (12.96%) were 
the most commonly prescribed drugs. Risperidone accounted for 
about 42.5% of the prescribed antipsychotics followed by olanzapine 
(23.33%) and quetiapine (15%). Among the anticonvulsants, 
topiramate (36.58%) and valproic acid (36.58%) were frequently 
prescribed. Vitamin and mineral supplements (63.7%) followed by 
trihexyphenidyl (20.74%) were the most commonly prescribed drugs 
among other psychotropic drugs (Table 1).
A total of 202 prescriptions containing 686 drugs were analyzed. 
Polypharmacy was found in 93.56% of the prescriptions with an 
average of 3.396 drugs/prescription. Polypharmacy was found to be 
more among the age group 25-35 years (34.39%). Drugs prescribed 
in their generic name constituted 39.94% while the prescriptions with 
injectable drugs accounted for 2.04% and 0.01% of the prescription 
contained psychotropic fixed dose combination (FDC). 27.98% of the 
psychotropic drugs were prescribed from WHO’s 18th List of Essential 
Medicines (Table 2).
DISCUSSION
Psychotropics remain a mainstay in the treatment of psychiatric illness. 
Drug utilization studies of psychotropic drugs reflect the present trends 
in therapeutic decision making. In this study, a total of 202 prescriptions 
were analyzed, of which, 129 (63.86%) were males and 73 (36.13%) 
were females which is in concordance with the study conducted by 
Kumar et al. [11]. The male preponderance in the present study can be 
attributed to the morbidity pattern observed with substance-related 
disorders (alcohol dependence syndrome and nicotine dependence 
syndrome) as the most common psychiatric disorder.
According to present findings, the majority of the patients belonged to 
25-35 years age group which was found similar to the study conducted 
by Sarumathy et al., wherein more than 66% of patients belonged to 
21-40 years of age group [12]. Morbidity pattern among psychiatric 
disorders showed substance-related disorders (28.71%) as the most 
common psychiatric disorder followed by schizophrenia and other 
psychotic disorders (22.77%). This is in contrary to the multicentric 
study conducted by the Indian Psychiatric Society where affective 
disorders followed by neurotic, stress-related, and somatoform 
disorders were the most common diagnostic categories [13]. Higher 
prevalence of substance use disorders in the present study may be 
probably due to increase help-seeking behavior for the same in the 
study population.
The drug utilization pattern in the study population showed BZDs 
(28.96%) as the most commonly prescribed psychotropic drug class 
followed by antipsychotics (18.18%) and antidepressants (18.18%). In 
our study, more than half of the psychotic patients received adjunctive 
BZD, clonazepam (47.89%) being the most common BZD followed 
by diazepam (21.05%) and lorazepam (18.95%). Similar findings 
were found in a study carried out by Rode et al., which showed the 
prescribing frequency of anxiolytics, antidepressants, antipsychotics, 
anticholinergics, and antimania drugs as 30.04%, 25.46%, 25.37%, 
11.54%, and 7.6%, respectively [14].
Prescribing pattern of antipsychotics in our study showed 
increased usage of atypical antipsychotics (18.8%) compared to 
typical antipsychotics (2.02%). Risperidone (42.5%) was the most 
commonly prescribed antipsychotic followed by olanzapine (23.33%). 
Prescriptions consisting of typical antipsychotics were found to be 
less, wherein chlorpromazine and haloperidol being the only drugs 
prescribed (5% each). This is similar to the results from the preliminary 
Fig. 1: It depicts distribution of psychiatric disorders
Table 1: Utilization of psychotropics in psychiatric OPD
Drug class Number of drugs (%)
Antidepressants 108 (18.18)
Atypical antipsychotics 108 (18.18)
Typical antipsychotics 12 (2.02)
Benzodiazepines 172 (28.96)




Mood stabilizers 14 (2.356)
Vitamin and mineral supplements 89 (14.99)
Total 594 (100)
OPD: Outpatient department
Table 2: Drug use pattern of psychotropics in psychiatric OPD
Drug use indicators Result
Total number of prescriptions analyzed 202
Total number of drugs prescribed 686
Average number of the drugs per prescription 3.396
Average number of the psychotropic per drugs per 
prescription
2.56
Percentage of the psychotropic drugs prescribed by 
generic name (%)
39.94
Percentage of injectable drugs prescribed (%) 2.04
Percentage of the prescriptions containing psychotropic 
FDC (%)
0.01
Percentage of psychotropic drugs prescribed from 
essential drug list (%)
27.98
OPD: Outpatient department, FDC: Fixed dose combination
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survey on antipsychotic prescribing pattern conducted among Indian 
Psychiatrists [15]. The most commonly prescribed antidepressant 
medication according to our study was escitalopram (57.40%) 
followed by sertraline (12.96%) which was similar to the findings from 
a multicentric study conducted by the Indian Psychiatry Society [13]. 
However, among the mood stabilizers, lithium and sodium valproate 
were commonly prescribed, followed by carbamazepine which is in 
contrary to study conducted by the Indian Psychiatry Society and in 
concordance with the study conducted by Trivedi et al. [13,16]. The 
WHO guidelines state that the number of antipsychotic drugs per 
prescription should be within 1.6-1.8/encounter, our study showed 
3.39, which is considerably more. In our study, around 60% of the 
prescriptions consisted of 1-3 drugs and 40% of the prescriptions 
contained four or more drugs. These findings suggested a rise in the 
incidence of polypharmacy with high prevalence among 25-35 years 
age group which is supported by a study conducted by Deshmukh 
and Ismail [5]. Polypharmacy can lead to poor compliance, drug 
interactions, adverse drug reactions, under-use of effective treatments 
and medication errors [17]. The reason for polypharmacy in our study 
may be attributed to the complexity of presentation in psychiatric 
illness and the presence of comorbidities. Generic drug usage reduces 
the overall cost of therapy, but our study revealed a low percentage of 
generic drug usage (39.94%) compared to brand drug usage (60.06%). 
The prescriptions containing psychotropic FDCs were very minimal 
0.01% which may be due to unavailability of expected FDC in the 
market. Concerns about the adverse effects and cost-effectiveness of 
parenteral routes of drug administration are probably the reason for 
the low utilization of “depot injection” formulation in the study (2.04%). 
The percentage of drugs prescribed from the WHO Essential Drug List 
was found to be 27.98, and the primary purpose of WHO Essential 
Drug List is to promote rational use of medicines considering the three 
important aspects, i.e., cost, safety, and efficacy. Our study suggests a 
strong need for creating awareness in the prescribers regarding the 
usage of generic drugs as they are cost-effective compared to brand 
drugs.
CONCLUSION
Continuous monitoring of the prescription gives an insight of present 
trends in prescribing patterns of psychotropic drugs in hospital 
settings. The drug use pattern from the study largely conforms 
to the standard recommendations of WHO. The commonly used 
psychotropic drug in the present study was BZDs. The incidence of 
polypharmacy should be minimized in psychiatric outpatients as it 
might result in poor compliance, increased drug interactions, and side 
effects. The generic drug usage is a rational prescribing indicator, and 
the issue of brand drug use needs to be addressed. Our study suggests 
a strong need for creating awareness in the prescribers regarding 
the usage of generic drugs as they are cost-effective compared to 
brand drugs. Our study was carried out for a short duration and 
study subjects were largely confined to OPD. Thus, the present study 
provides a baseline to conduct drug utilization studies periodically 
for a longer duration in a larger sample size to influence the overall 
improvement of patients on psychotropic drugs in different mental 
health care settings.
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